Garrett FitzGerald and Carlo Patrono Share 2013 Grand Prix Scientifique

April 18, 2013

PHILADELPHIA, PA and ROME, ITALY — Dr Garrett FitzGerald (University of Pennsylvania, PA) and DrCarlo Patrono (Catholic University, Rome, Italy) are the 2013 winners of the GrandPrix Scientifique from the Lefoulon-Delalande Foundation of the Institute of France[1]. The researchers share the prize for their work in the development of low-dose aspirin for the prevention of cardiovascular disease.

"I am delighted to receive this honor," FitzGerald stated in a press release. "However, it reflects the creativity, focus, and hard work of so many people with whom I have been privileged to work. It is a particular pleasure to share this prize with Carlo, with whom I have collaborated and competed, but most importantly, shared a special friendship for more than 30 years."

The Grand Prix Lefoulon-Delalande is one of the most prestigious and largest awards for cardiovascular research. The award, worth €500 000, was created by the Laboratories Delalande and is awarded to someone deemed to have made a significant scientific contribution to physiology, biology, or cardiovascular medicine. FitzGerald and Patrono received the award for using novel approaches to assess the formation of prostaglandins in blood clotting and for discovering how low-dose aspirin acts on platelets.

FitzGerald is the chair of the pharmacology department and director of the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania. He has previously been recognized by the Swedish Academy of Pharmaceutical Science, winning the Scheele Award, as well winning the Lucian Award from McGill University. Patrono is the chair of the department of pharmacology at the Catholic University in Rome and was previously awarded the Alexander Gutman award from Mount Sinai School of Medicine and the John Vane Award from the University of London, among other accolades.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.